Diffuse cutaneous systemic sclerosis

Disease ID:285
Name:Diffuse cutaneous systemic sclerosis
Associated with:1 target
1 immuno-relevant ligand
Database Links
Orphanet: ORPHA220393

Targets

CCR6

Ligands

Key to terms and symbols Click ligand name to view ligand summary Click column headers to sort
Ligand References Clinical and Disease comments
IL-13
Immuno Disease Comments: Drug target for diffuse systemic sclerosis- see Phase 2 trial NCT02921971 which is evaluating the anti-IL-4/IL-13 bispecific monoclonal antibody SAR156597.